In ambiguous immunophenotypes, indicators such as CD5, CD20, CD23, and CD200 for CLL and CD10, CD34, CD79, and CD99 for ALL, may help refine the diagnosis. This evidence concerns the gene CD99 and acute lymphoblastic leukemia.